Products

LISATHYONE Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable

    • Product Name: LISATHYONE Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 789318
    Product Name LISATHYONE
    Api Name Liothyronine Sodium
    Grade Pharma Grade API
    Therapeutic Category Thyroid Hormone
    Cas Registry Number 55-06-1
    Molecular Formula C15H11I3NNaO4
    Molecular Weight 672.96 g/mol
    Appearance White to off-white crystalline powder
    Solubility Slightly soluble in water; slightly soluble in ethanol
    Storage Conditions Store protected from light in a tightly closed container at 20-25°C
    Route Of Administration Oral and Injectable
    Dosage Forms Tablet, Capsule, Granule, Injection
    Purity 98.0% - 102.0% (dried basis)
    Pharmacopoeial Standard USP/BP/EP/IP
    Shelf Life 2 years when stored as directed
    Packaging Fiber drum with inner LDPE bags

    As an accredited LISATHYONE Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Free Quote

    Competitive LISATHYONE Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    Top